Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Screening for COVID-19 and Strict COVID Cancer Protocol Helps to Reduce Postoperative Infection, Mortality and Morbidity in Cancer Patients Undergoing Surgery. A Comparative Study

NCT05240378 is registered in ClinicalTrials.gov with Banaras Hindu University as lead sponsor.

NCT NCT05240378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Screening for COVID-19 and Strict COVID Cancer Protocol Helps to Reduce Postoperative Infection, Mortality and Morbidity in Cancer Patients Undergoing Surgery. A Comparative Study
Lead sponsor
Banaras Hindu University
Phase
Observational
Overall status
Completed
Start date
October 29, 2021
Completion date
January 15, 2022
Enrollment
1,576 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, sars cov 2 infection